Lista de obras - Pascale Trimoulet - Dominio Público Uruguay

A European multicentre study on the comparison of HCV viral loads between VERIS HCV assay and COBAS® TaqMan® HCV Test and RealTime HCV Assay

artículo científico publicado en 2017

A European multicientre study on the comparison of HBV viral loads between VERIS HBV assay and Roche COBAS® TAQMAN® HBV test, Abbott RealTime HBV assay, Siemens VERSANT HBV assay, and Qiagen artus HBV RG kit.

artículo científico publicado en 2017

A European multicientre study on the comparison of HIV-1 viral loads between VERIS HIV-1 Assay and Roche COBAS® TAQMAN® HIV-1 test, Abbott RealTime HIV-1 Assay, and Siemens VERSANT HIV-1 Assay

artículo científico publicado en 2017

Acute hepatitis associated with hepatitis G virus primo-infection in a renal transplant recipient

artículo científico publicado en 2004

Anti-hepatitis B virus efficacy of tenofovir disoproxil fumarate in HIV-infected patients

artículo científico publicado en 2006

Baseline and post-treatment hepatitis C NS5A resistance in relapsed patients from a multicentric real-life cohort

artículo científico

CD4 T lymphocyte proliferative responses to hepatitis C virus (HCV) antigens in patients coinfected with HCV and human immunodeficiency virus who responded to anti-HCV treatment

artículo científico publicado en 2002

Combined Analysis of the Prevalence of Drug-Resistant Hepatitis B Virus in Antiviral Therapy-Experienced Patients in Europe (CAPRE).

artículo científico

Comparison of 2 regimens that include interferon-alpha-2a plus ribavirin for treatment of chronic hepatitis C in human immunodeficiency virus-coinfected patients

artículo científico publicado en 2003

Daily or three times a week interferon alfa-2b in combination with ribavirin or interferon alone for the treatment of patients with chronic hepatitis C.

artículo científico publicado en 2002

Dynamic and rapid changes in viral quasispecies by UDPS in chronic hepatitis C patients receiving telaprevir-based therapy

artículo científico publicado en 2013

Epidemiological and phylogenetic evidence for patient-to-patient hepatitis C virus transmission during sclerotherapy of varicose veins

artículo científico publicado en 2005

Epidemiological, virological and clinical characteristics of HBV infection in 223 HIV co-infected patients: a French multi-centre collaborative study

artículo científico publicado en 2013

Estimation of dynamical model parameters taking into account undetectable marker values ⬇️

artículo científico publicado en 2006

European Multicenter Study on Analytical Performance of DxN Veris System HCV Assay

artículo científico publicado en 2017

Evaluation of the VERSANT HCV RNA 3.0 assay for quantification of hepatitis C virus RNA in serum

artículo científico publicado en 2002

Evolution of plasma hepatitis C virus load in patients coinfected by HIV and hepatitis C Virus started on a protease inhibitor-containing antiretroviral regimen, Agence Nationale de Recherches sur le SIDA CO8 APROCO-COPILOTE cohort

artículo científico publicado en 2008

Evolutionary history of hepatitis C virus genotype 5a in France, a multicenter ANRS study

artículo científico publicado en 2011

HIV and HCV co-infection: situation at six French university hospitals in the year 2000.

artículo científico publicado en 2003

HIV-1 tropism and liver fibrosis in HIV-HCV co-infected patients

artículo científico publicado en 2012

Hepatitis B virus genotypes: a retrospective survey in Southwestern France, 1999-2004.

artículo científico publicado en 2007

Hepatitis C virus RNA quantitation in a nationwide French cohort of patients co-infected with HIV and HCV: Should the same test be applied to all samples? ⬇️

artículo científico publicado el 20 de enero de 2012

Hepatitis C virus genetic variability in 52 human immunodeficiency virus-coinfected patients

artículo científico publicado en 2003

Influence of the HCV subtype on the virological response to pegylated interferon and ribavirin therapy

artículo científico publicado en 2009

Interpretation of real-time PCR results for hepatitis C virus RNA when viral load is below quantification limits

artículo científico publicado en 2011

Multicenter Trials Need To Use the Same Assay for Hepatitis C Virus Viral Load Determination

artículo científico publicado en 2007

Multicenter quality control of hepatitis C virus protease inhibitor resistance genotyping

artículo científico publicado en 2013

NS3 protease polymorphism and natural resistance to protease inhibitors in French patients infected with HCV genotypes 1-5.

artículo científico publicado en 2011

Natural non-homologous recombination led to the emergence of a duplicated V3-NS5A region in HCV-1b strains associated with hepatocellular carcinoma

artículo científico publicado en 2017

Natural prevalence of hepatitis C virus (HCV) variants resistant to protease and polymerase inhibitors in patients infected with HCV genotype 1 in Tunisia

artículo científico publicado en 2014

Naturally Occurring Resistance-Associated Variants of Hepatitis C Virus Protease Inhibitors in Poor Responders to Pegylated Interferon-Ribavirin

artículo científico publicado en 2015

Neutralizing antibodies to interferon‐α and circulating interferon in patients with chronic hepatitis C non‐responding to pegylated interferon plus ribavirin re‐treated by pegylated interferon‐α‐2a and ribavirin (ANRS HC16 GAMMATRI substudy*) ⬇️

artículo científico publicado el 1 de diciembre de 2010

Outbreak of hepatitis C virus infection during sclerotherapy of varicose veins: long-term follow-up of 196 patients (4535 patient-years).

artículo científico publicado en 2006

Overlapping structure of hepatitis B virus (HBV) genome and immune selection pressure are critical forces modulating HBV evolution

artículo científico publicado en 2012

Plasma and Liver Hepatitis C Virus Variability in Patients Coinfected with Human Immunodeficiency Virus

artículo científico publicado en 2006

Predictive value of early HCV RNA quantitation for sustained response in nonresponders receiving daily interferon and ribavirin therapy

artículo científico publicado en 2004

Prevalence of hepatitis C virus (HCV) variants resistant to NS5A inhibitors in naïve patients infected with HCV genotype 1 in Tunisia

artículo científico publicado en 2015

Ribavirin plasma concentration predicts sustained virological response to peginterferon Alfa 2a plus ribavirin in previously treated HCV-HIV-coinfected patients

artículo científico publicado en 2009

Role of hepatitis B virus genetic barrier in drug-resistance and immune-escape development

artículo científico publicado en 2011

Seven nucleotide changes characteristic of the hepatitis C virus genotype 3 5' untranslated region: correlation with reduced in vitro replication

artículo científico publicado en 2008

Lista de obras de Pascale Trimoulet

A European multicentre study on the comparison of HCV viral loads between VERIS HCV assay and COBAS® TaqMan® HCV Test and RealTime HCV Assay

A European multicientre study on the comparison of HBV viral loads between VERIS HBV assay and Roche COBAS® TAQMAN® HBV test, Abbott RealTime HBV assay, Siemens VERSANT HBV assay, and Qiagen artus HBV RG kit.

A European multicientre study on the comparison of HIV-1 viral loads between VERIS HIV-1 Assay and Roche COBAS® TAQMAN® HIV-1 test, Abbott RealTime HIV-1 Assay, and Siemens VERSANT HIV-1 Assay

Acute hepatitis associated with hepatitis G virus primo-infection in a renal transplant recipient

Anti-hepatitis B virus efficacy of tenofovir disoproxil fumarate in HIV-infected patients

Baseline and post-treatment hepatitis C NS5A resistance in relapsed patients from a multicentric real-life cohort

CD4 T lymphocyte proliferative responses to hepatitis C virus (HCV) antigens in patients coinfected with HCV and human immunodeficiency virus who responded to anti-HCV treatment

Combined Analysis of the Prevalence of Drug-Resistant Hepatitis B Virus in Antiviral Therapy-Experienced Patients in Europe (CAPRE).

Comparison of 2 regimens that include interferon-alpha-2a plus ribavirin for treatment of chronic hepatitis C in human immunodeficiency virus-coinfected patients

Daily or three times a week interferon alfa-2b in combination with ribavirin or interferon alone for the treatment of patients with chronic hepatitis C.

Dynamic and rapid changes in viral quasispecies by UDPS in chronic hepatitis C patients receiving telaprevir-based therapy

Epidemiological and phylogenetic evidence for patient-to-patient hepatitis C virus transmission during sclerotherapy of varicose veins

Epidemiological, virological and clinical characteristics of HBV infection in 223 HIV co-infected patients: a French multi-centre collaborative study

Estimation of dynamical model parameters taking into account undetectable marker values ⬇️

European Multicenter Study on Analytical Performance of DxN Veris System HCV Assay

Evaluation of the VERSANT HCV RNA 3.0 assay for quantification of hepatitis C virus RNA in serum

Evolution of plasma hepatitis C virus load in patients coinfected by HIV and hepatitis C Virus started on a protease inhibitor-containing antiretroviral regimen, Agence Nationale de Recherches sur le SIDA CO8 APROCO-COPILOTE cohort

Evolutionary history of hepatitis C virus genotype 5a in France, a multicenter ANRS study

HIV and HCV co-infection: situation at six French university hospitals in the year 2000.

HIV-1 tropism and liver fibrosis in HIV-HCV co-infected patients

Hepatitis B virus genotypes: a retrospective survey in Southwestern France, 1999-2004.

Hepatitis C virus RNA quantitation in a nationwide French cohort of patients co-infected with HIV and HCV: Should the same test be applied to all samples? ⬇️

Hepatitis C virus genetic variability in 52 human immunodeficiency virus-coinfected patients

Influence of the HCV subtype on the virological response to pegylated interferon and ribavirin therapy

Interpretation of real-time PCR results for hepatitis C virus RNA when viral load is below quantification limits

Multicenter Trials Need To Use the Same Assay for Hepatitis C Virus Viral Load Determination

Multicenter quality control of hepatitis C virus protease inhibitor resistance genotyping

NS3 protease polymorphism and natural resistance to protease inhibitors in French patients infected with HCV genotypes 1-5.

Natural non-homologous recombination led to the emergence of a duplicated V3-NS5A region in HCV-1b strains associated with hepatocellular carcinoma

Natural prevalence of hepatitis C virus (HCV) variants resistant to protease and polymerase inhibitors in patients infected with HCV genotype 1 in Tunisia

Naturally Occurring Resistance-Associated Variants of Hepatitis C Virus Protease Inhibitors in Poor Responders to Pegylated Interferon-Ribavirin

Neutralizing antibodies to interferon‐α and circulating interferon in patients with chronic hepatitis C non‐responding to pegylated interferon plus ribavirin re‐treated by pegylated interferon‐α‐2a and ribavirin (ANRS HC16 GAMMATRI substudy*) ⬇️

Outbreak of hepatitis C virus infection during sclerotherapy of varicose veins: long-term follow-up of 196 patients (4535 patient-years).

Overlapping structure of hepatitis B virus (HBV) genome and immune selection pressure are critical forces modulating HBV evolution

Plasma and Liver Hepatitis C Virus Variability in Patients Coinfected with Human Immunodeficiency Virus

Predictive value of early HCV RNA quantitation for sustained response in nonresponders receiving daily interferon and ribavirin therapy

Prevalence of hepatitis C virus (HCV) variants resistant to NS5A inhibitors in naïve patients infected with HCV genotype 1 in Tunisia

Ribavirin plasma concentration predicts sustained virological response to peginterferon Alfa 2a plus ribavirin in previously treated HCV-HIV-coinfected patients

Role of hepatitis B virus genetic barrier in drug-resistance and immune-escape development

Seven nucleotide changes characteristic of the hepatitis C virus genotype 3 5' untranslated region: correlation with reduced in vitro replication